Skip to main content

Face masks and social distancing: Due to the rising prevalence of COVID-19 in our communities, we strongly encourage healthcare staff and visitors to wear a face covering in all of our settings, particularly in clinical areas and those with high footfall. Please exercise a common-sense approach and personal responsibility to help us reduce the impact of COVID-19 on our patients, workforce and services. In addition to wearing a face covering, it is important to continue to maintain social distancing where possible. Thank you for your continued support and co-operation at this time. We continue to regularly review our advice based on prevalence in our communities and our hospitals.

Sponsor information

An animated image of a hand shake

The UK Policy Framework for Health and Social Care Research (2017) requires all studies to have an identified Sponsor within the UK. The Sponsor is an institution or organisation that takes on the legal responsibility for the initiation, management and conduct of the research study.

Swansea Bay University Health Board operates a Co- Sponsorship model with Swansea University Trials Unit for all clinical intervention studies.

Protocol development

The research protocol provides a detailed description of the objectives, design, methodology, statistical consideration and management of a research study.  All protocols must be peer reviewed for scientific quality and relevance as part of research governance requirements.

Usually as part of the funding process, funders would have undertaken a robust peer review of the protocol, equally external Sponsors are responsible for peer review prior to submitting protocols to R&D for approval.

For all in-house Sponsored studies, the Health Board operates a Joint Study Review Committee with Swansea University.

The Committee meets monthly and in particular can offer in-depth statistical and randomisation advice to researchers’ through the support and collaboration of the UKCRC registered Clinical Trials Unit STU, based within the University.

Under the co-sponsorship model, usually all in-house Swansea Bay University Health Board clinical interventional studies will be developed in collaboration with Swansea Trials Unit.

Insurance and Indemnity

Insurance and indemnity is a pre-requisite for all clinical research and is the responsibility of the Sponsor. A clear statement of who is providing cover and under what circumstances should appear in the study protocol, the participant information sheet and ethics application form.

 Commercial or other non-commercial Sponsors of research will be responsible for providing indemnity and extending this indemnity to the Health Board.

Standard Operating Procedures (SOPS)

Research Governance and Good Clinical Practice (GCP) places a responsibility on Sponsors and NHS sites to implement Standard Operating Procedures (SOPs) for every aspect of clinical trial management. Swansea Bay UHB currently utilise Standard Operating Procedures issued by Swansea Trials Unit available here alongside local SOPs available here.

Find us on

Rydym yn croesawu gohebiaeth a galwadau ffôn yn y Gymraeg neu'r Saesneg. Atebir gohebiaeth Gymraeg yn y Gymraeg, ac ni fydd hyn yn arwain at oedi. Mae’r dudalen hon ar gael yn Gymraeg drwy bwyso’r botwm ar y dde ar frig y dudalen.

We welcome correspondence and telephone calls in Welsh or English. Welsh language correspondence will be replied to in Welsh, and this will not lead to a delay. This page is available in Welsh by clicking ‘Cymraeg’ at the top right of this page.